Skip to main content
Premium Trial:

Request an Annual Quote

Nucleonics Challenges Benitec Patent Application in Poland

NEW YORK, March 4 (GenomeWeb News) - Nucleonics is challenging a patent held by Benitec in Poland, the company said yesterday.


Nucleonics said it filed prior art citations, also called a third party observation, with the Polish Patent Office. This prior art, it believes, invalidates claims in Benitec's patent application No. PL 343 064, "Control of Gene Expression." According to Nucleonics, these claims are ambiguous because they lack novelty or did not involve an inventive step at the time the patent application was filed.


The latest filing follows a number of challenges of Benitec patents by Nucleonics in other countries. Last year, Nucleonics requested the reexamination of two Benitec patents in Australia, and of one Benitec patent in the US. In January, Nucleonics also filed a third-party observation challenging Benitec's patent application in Europe.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.